PEDER K. JENSEN, M.D.

Corporate Board Profile

Tech Score: 0/100

BIOCRYST PHARMACEUTICALS INC

Filing Date	Source Excerpt
2015-04-10	Peder K. Jensen, M.D., age 60, was appointed to the Board in May 2011. Dr. Jensen serves as a member of the Compensation Committees at Acorda and FivePrime, as a member of the Compliance Committee as Acorda and as chair person of the Government and Nomination Committee at FivePrime. The Audit Committee currently consists of Mr. Lee, as chairperson, Mr. Abercrombie and Dr. Jensen. The Compensation Committee during 2014 consisted of Mr. Erck, Mr. Abercrombie, Dr. Sanders and Dr. Jensen. The Corporate Governance and Nominating Committee consisting of Dr. Hutson, Dr. Jensen and Mr. Abercrombie. The 2014 Director Compensation table shows Peder K. Jensen, M.D. received total compensation of $141,738.

Filing Date

Source Excerpt

2015-04-10

Peder K. Jensen, M.D., age 60, was appointed to the Board in May 2011. Dr. Jensen serves as a member of the Compensation Committees at Acorda and FivePrime, as a member of the Compliance Committee as Acorda and as chair person of the Government and Nomination Committee at FivePrime. The Audit Committee currently consists of Mr. Lee, as chairperson, Mr. Abercrombie and Dr. Jensen. The Compensation Committee during 2014 consisted of Mr. Erck, Mr. Abercrombie, Dr. Sanders and Dr. Jensen. The Corporate Governance and Nominating Committee consisting of Dr. Hutson, Dr. Jensen and Mr. Abercrombie. The 2014 Director Compensation table shows Peder K. Jensen, M.D. received total compensation of $141,738.

Data sourced from SEC filings. Last updated: 2026-02-03